|
Optimise healing with post-operative dressing change protocols
Operating in over 40 countries around the globe, Mölnlycke Health Care is a world-leading company that designs and supplies medical solutions to enhance performance in healthcare from the hospital to the home.
Effective wound-bed preparation
Correct wound bed preparation in chronic wounds accelerates healing and enhances the effectiveness of advanced wound care products. Katie Bennett – an NHS nurse with special interest in tissue viability, who runs a leg ulcer clinic, and treats complex and challenging wounds – explains why B Braun’s Prontosan Irrigation Solution, Wound Gel X and Debridement Pad provide the best foundation for wound healing.
Enable early detection of congenital CMV infection
For over 40 years, DiaSorin Molecular has been developing, producing and commercialising diagnostic tests in a wide range of clinical areas including paediatrics, oncology, women’s health and infectious diseases. The company is about to launch its first Simplexa kit for the detection of congenital human cytomegalovirus (CMV), which poses significant dangers to newborns all across the globe.
Treat chronic wounds with a haemoglobin-based spray
Mölnlycke’s Granulox, a topical haemoglobin-based spray for the treatment of chronic wounds, improves patient outcomes by oxygenating the base of their wounds and has been shown to result in shorter healing time, reduced pain scores and total cost savings for healthcare providers compared with the standard of care. Diabetic foot specialist Rosalyn Thomas explains how it has contributed to her practice.
Combat the spread of infectious disease
The past few months has shown that a team’s rapid response to expediting an assay globally, dedicated to the detection of SARS-CoV-2, is possible. BioGX, in a long-term partnership with Becton, Dickinson and Company, has submitted a test to the FDA for emergency use authorisation (EUA) in the US, in parallel to CE-IVD approval. In these challenging times, laboratories around the world have an urgent need for an easy-to-use, reliable test to detect SARS-CoV-2 to determine if patients have contracted COVID-19. Authorisation to use these tests worldwide would increase access to highly reliable results.
|
